Johnson & Johnson reports fiscal Q3 2026 results: revenue $25.40B, up 6% from a year earlier

Johnson & Johnson filed a Form 8-K with the SEC on Oct 13, 2026, 8:12 AM ET, reporting an event dated Oct 13, 2026. It covers Item 2.02 (Results of Operations and Financial Condition); Item 9.01 (Financial Statements and Exhibits). The results cover fiscal Q3 2026 (quarter ended Sep 27, 2026); figures below are from the company's XBRL financial data filed with the SEC.

• Revenue: $25.40B (+5.9% from $23.99B a year earlier)
• Net income: $210.0M (−95.9% from $5.15B a year earlier)
• Diluted EPS: $0.09 (−95.8% from $2.12 a year earlier)
• Form 8-K accepted by EDGAR Oct 13, 2026, 8:12 AM ET
• Accession number 0000200406-26-000189

SEC filing 8-K · accession 0000200406-26-000189 · sec.gov ↗